Skip to main content
. 2022 Jan 19;60(1):e01410-21. doi: 10.1128/JCM.01410-21

TABLE 2.

Summary of omadacycline MTS reproducibility results by organism group and isolate for all testing sites

Organism group (all-site and -isolate essential agreement) Reproducibility strain no., species
No. of results at 2-fold dilution differencea,b
–2 –1 0 1 2
Gram Negative (270 of 270 results[100%]) R1, E. coli 27 0.5
R2, E. coli 26 1 1
R3, E. coli 26 1 2
R4, E. coli 11 16 8
R5, K. pneumoniae 14 13 1
R6, K. pneumoniae 12 14 1 4
R7, K. pneumoniae 8 19 8
R8, E. cloacae 11 16 2
R9, E. cloacae 5 22 2
R10, E. cloacae 8 9 2
Gram Positive (257 of 270 results [95.2%]) R1, MSSA 10 15 2 0.25
R5, MSSA 3 21 3 1
R8, MRSA 12 8 7 0.12
R10, MRSA 5 22 2
R11, S. lugdunensis 6 21 0.12
R12, S. lugdunensis 4 21 2 0.12
R14, E. faecalis (VSE) 2 24 1 0.12
R15, E. faecalis (VSE) 18 7 2 4
R16, E. faecalis (VRE) 1 17 9 0.12
R17, E. faecalis (VRE) 12 11 4 1
Fastidious
HTM and MHA-SB (295 of 297 results [99.3%])
R1, S. pneumoniae 1 18 8 0.5
R2, S. pneumoniae 6 21 0.12
R3, S. pneumoniae 9 18 1
R6, H. influenzae 1 24 2 2
R7, H. influenzae 13 14 1
R11, S. pyogenes 16 11 0.12
R12, S. anginosus 19 8 0.5
R14, S. constellatus 1 19 6 1 0.12
R15, H. parainfluenzae 24 3 2
R16, S. pyogenes 1 22 4 0.25
R17, S. anginosus 12 15 0.12
Fastidious
MH-F (266 of 270 results [98.5%])
R1, S. pneumoniae 20 7 0.5
R2, S. pneumoniae 1 26 0.12
R3, S. pneumoniae 2 24 1 1
R6, H. influenzae 1 25 1 2
R7, H. influenzae 21 6 0.5
R11, S. pyogenes 3 24 0.25
R12, S. anginosus 18 9 0.5
R13, S. intermedius 4 8 15 0.03
R14, S. constellatus 1 15 11 0.12
R15, H. parainfluenzae 2 25 2
a

Essential agreement pertains to the shaded results, which are within ±1 dilution of the modal MIC.

b

The 2-fold dilution difference is the difference between each MIC and the modal MIC for all results.